A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)
Clinical trial NCT04663308 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04663308
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-18
- Primary completion
- 2026-06-01
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.